Big Pharma duels with pharmacies in funding fight

Published



The pharmaceutical industry is trying to head off a congressional push to loosen regulations for compounding pharmacies, a cheaper competitor.

Several pharmaceutical trade groups and public advocacy groups Pew Charitable Trusts and Trust for America’s Health wrote to Senate leaders Wednesday to keep regulations for compounding pharmacies intact. The impetus was a provision tucked into a House appropriations bill that would loosen compounding regulations.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.